| Pharmaceutical Information |
| Drug Name |
Fosaprepitant |
| Drug ID |
BADD_D00962 |
| Description |
Fosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. |
| Indications and Usage |
For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB06717
|
| KEGG ID |
D10895
|
| MeSH ID |
C579707
|
| PubChem ID |
135413538
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
43598-948; 72205-054; 72205-083; 16714-929; 68180-690; 43598-859; 71839-104; 63323-972; 70710-1615; 16729-240; 68001-517; 0781-3497; 68001-421; 16714-120; 69539-181; 72205-026; 60505-6105; 69097-830; 69539-034; 67457-889; 0591-4385 |
| UNII |
6L8OF9XRDC
|
| Synonyms |
fosaprepitant | Emend for injection | fosaprepitant dimeglumine | L 785,298 | L785,298 | L-785,298 |
|
| Chemical Information |
| Molecular Formula |
C23H22F7N4O6P |
| CAS Registry Number |
172673-20-0 |
| SMILES |
CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(
C=C4)F |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
